Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Imugene Reports Net Loss of $14.83m for Half-Year to 31 December 2021

18 May 2022  |  13:34:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Half Yearly Report and Accounts

Imugene reported net loss of $14.83m for the half-year ended 31 December 2021. Revenue from ordinary activities were nil. Basic and Diluted EPS were (0.27) cents compared to (0.13) cents last year. The net operating cash outflow was $10.4m compared to an outflow of $4.06m in the pcp. No dividend was declared.

Imugene Half Year Results to 31 December 2021

6 Months to 31 December 2021 ($A'000) 6 Months to 31 December 2020 ($A'000)
Revenue nil nil
Pre-Tax Profit (Loss) (14,832.367) (6,062.737)
Net Profit (Loss) (14,832.367) (6,062.737)
Operating Cash Flow (10,400.768) (4,060.725)
Interim Dividends (cents) nil nil
Basic and Diluted EPS (cents) (0.27) (0.13)
NTA (cents) 2.04 0.69
Please click here for full details

See more ASX300 News Announcements